0001209191-18-007146.txt : 20180202
0001209191-18-007146.hdr.sgml : 20180202
20180202181722
ACCESSION NUMBER: 0001209191-18-007146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180131
FILED AS OF DATE: 20180202
DATE AS OF CHANGE: 20180202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Gregory
CENTRAL INDEX KEY: 0001329505
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 18572257
MAIL ADDRESS:
STREET 1: 4 A CHESHAM STREET
CITY: LONDON
STATE: X0
ZIP: SW1X8DT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 234 CHURCH STREET, SUITE 304
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 234 CHURCH STREET, SUITE 304
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-31
0
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001329505
Bailey Gregory
C/O BIOHAVEN PHARMACEUTICALS, INC.
234 CHURCH STREET
NEW HAVEN
CT
06510
1
0
0
0
Common Shares
2018-01-31
4
S
0
8400
32.63
D
2516701
D
Common Shares
2018-01-31
4
S
0
18280
33.42
D
2498421
D
Common Shares
2018-01-31
4
S
0
23320
34.32
D
2475101
D
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on August 19, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.07 - $33.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.07 - $34.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.08 - $34.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
/s/ Darren K. DeStefano, attorney-in-fact
2018-02-02